Flexion Therapeutics Stock News

BURLINGTON, Mass. (AP) _ Flexion Therapeutics Inc. (FLXN) on Thursday reported a loss of $33.5 million in its fourth quarter. The Burlington, Massachusetts-based company said it had a loss of 88 cents

BURLINGTON, Mass. (AP) _ Flexion Therapeutics Inc. (FLXN) on Thursday reported a loss of $33.5 million in its fourth quarter. The Burlington, Massachusetts-based company said it had a loss of 88 cents

Flexion Therapeutics, Inc. (FLXN) today reported financial results and recent business highlights for the quarter and the full year ended December 31, 2019. “2019 marked an exciting period of growt

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) * Bicycle Therapeutics PLC (NASDAQ: BCYC) (reacte

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) Bicycle Therapeutics...

Flexion Therapeutics, Inc. (FLXN) today announced that Melissa Layman has been named Chief Commercial Officer (CCO). Ms. Layman joins Flexion with more than 25 years of commercial experience within t

BURLINGTON, Mass., March 11, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Melissa Layman has been named Chief...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aurinia Pharmaceuticals (AUPH), BioCryst (BCRX) and Flexion Therapeutics

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aurinia Pharmaceuticals ( AUPH – Research Report ), BioCryst ( BCRX – Research Report ) and Flexion Therapeutics (

Artisan Partners Limited Partnership acquired a new position in shares of Flexion Therapeutics Inc (NASDAQ:FLXN) in the 4th quarter, according to the company in its most recent Form 13F filing with th

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccin

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and...

New York State Common Retirement Fund reduced its stake in Flexion Therapeutics Inc (NASDAQ:FLXN) by 17.8% during the 4th quarter, according to the company in its most recent 13F filing with the Secur

The Compensation Committee of the Board of Directors approved the grants with an effective date of March 2, 2020. The stock options and restricted stock units were granted as inducements material to